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Introduction 
The International Continence Society (ICS) 
terminology for lower urinary tract dysfunction 
(LUTD) from 2003, which can be divided into 
storage symptoms and voiding symptoms, 
defines urinary incontinence (UI) as a storage 
symptom and as the complaint of any 
involuntary loss of urine (1). UI can also be 
defined as the inability to control urination which 
is manifested in the range from temporary 
leakage of urine to complete involuntary voiding 
which can be seen as a social and hygienic 
problem (2, 3). The anatomical structures of the 
female reproductive and urinary system are 
closely related, which leads to the conclusion 
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that urinary problems interfere with sexual 
health in females (4). According to the current 
World Health Organization definition, sexual 
health is a state of physical, emotional, mental 
and social well-being in relation to sexuality, it is 
not merely the absence of disease, dysfunction 
or infirmity (5). The normal male sexual response 
cycle can be divided into libido, erection, 
ejaculation, orgasm and detumescence (6). 
Sexual response cycle in women can be divided 
into libido, arousal, orgasm and satisfaction (7). 
Damage of the integrity of the sexual response 
cycle, which is essential to human sexual 
functioning, may result in sexual dysfunction (8). 
Female sexual dysfunction has been 
characterized as a persistent, recurrent problem 
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with sexual response, sexual desire, arousal, 
orgasm or dyspareunia and vaginismus that 
distresses the affected or strains the relationship 
with their partner (9). As reported by the 
International Urogynecological Association and 
the International Continence Society in 2010, 
incontinence during sexual intercourse or coital 
urinary incontinence (CUI) is defined as the 
complaint of involuntary loss of urine during 
coitus (10). The objective of this study was to 
review the available evidence on incidence, 
prevalence, pathophysiology and treatment of 
UI and coital urinary incontinence (CUI) with the 
attempt to determine the impact of UI and its 
physical and psychological consequences on 
women's sexual health and function in order to 
advise in a timely manner, prevent and treat 
disorders associated with bladder control issues. 
Urinary incontinence – definition, 
etiopathogenesis, epidemiology 
Women seldom visit general practitioners 
regarding incontinence problems which occur 
during or independently of the sex act, being 
that they are not familiar with the possibilities of 
treatment and mainly because a lot of women 
are ashamed to admit their “condition” unless 
they are precisely inquired by specialists or 
asked to “fill out” related questionnaires (11, 12). 
UI has a negative impact on sexual health 
irrespective of whether or not unwanted urine 
leakage occurs during sexual intercourse (4). UI 
products (e.g. incontinence pads, diapers) keep 
women dry but wearing them all day can cause 
chronic skin changes of the genital region which 
leads to discomfort and pain especially 
throughout sexual intercourse (13). Furthermore, 
worrying about urinary leakage and odor during 
intercourse can cause feelings of anger, 
sadness, embarrassment, despair and low self-
esteem. Consequently, women abstain from 
having intercourse, which can cause reduction in 
the frequency of sexual relations, reduction of 
sexual desire and ability to achieve an orgasm. 
What's more, men no longer find their partner 
sexually attractive and some men even 
experience erectile dysfunction (14, 15). The 
pathophysiology and frequency of CUI and 
impact of CUI on quality of life are still not 
conclusive because there is limited research 
data. UI is not a disease but a symptom that is 
caused by disorders of pelvic floor muscles, the 
urethral sphincter and bladder. UI is most 
commonly divided into 3 types: stress urinary 
incontinence (SUI) which is most prevalent (51%), 
urge urinary incontinence (UUI) (10%) and mixed 
urinary incontinence (MUI) (39%) (16). In women 
with SUI, involuntary urine leakage occurs 
during coughing, laughing, sneezing and other 
physical activities (e.g. exercise, lifting heavy 
objects, sexual intercourse). UUI is associated 
with an overwhelming urge to urinate that 
cannot be suppressed or delayed and is caused 
by detrusor overactivity. MUI is defined as the 
involuntary leakage of urine accompanied by a 
sense of urgency during physical exertion, 
exercise, sneezing or coughing. Urine loss 
during sexual activity may occur during arousal, 
penetration, orgasm, or resolution. Current 
research suggests that in women with SUI 
episodes of urine leakage are more likely to 
occur with penetration due to pressure on the 
bladder but in the case of UUI urine is more likely 
to leak during orgasm (17). In this fashion, we can 
determine two types of CUI: incontinence during 
penetration and incontinence at orgasm (17). Risk 
factors for the occurrence of UI are sex, age, 
cigarette smoking and high body mass index 
(BMI) (18). UI is three times more common in 
women than in men regardless of the type (19). 
The prevalence of UI increases with age and in 
women between 15 and 60, it ranges from 10 to 
25% (20). In older age groups, the number of 
incontinent women is higher although the vast 
majority of older women have acceptable 
control over their urination. Among women aged 
60 and over, prevalence of UI is 38% (21). The 
prevalence of female sexual dysfunction is 
estimated to be 43% and it increases with age 
(22). The incidence for each type of UI in females 
ranges between 10% and 58% depending on the 
observed population. It is generally accepted 
that the etiology of UI in women is associated 
with vaginal delivery, especially the first vaginal 
birth, menopause and surgical procedures in the 
pelvis and abdomen (23). The particular obstetric 
event that causes incontinence has not been 
found but it is most likely associated with 
newborns with an excessive birth weight and 
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difficult deliveries marked by prolonged pushing 
phases with or without instrumentation, which 
lead to nerve and muscle damage that provide 
a physiologic basis for this association (24). It is 
important to note that not all women who have 
had vaginal delivery experience symptoms of UI 
but they have more bothersome symptoms than 
women who have never had children. Hormone 
changes in menopause and surgical procedures 
can also affect muscle strength in the pelvic 
region. Cigarette smoking can induce chronic 
obstructive pulmonary disease with chronic 
cough that in time weakens the lower pelvic 
floor muscles and causes symptoms of SUI but 
on top of that, ingredients of cigarette smoke 
can cause urinary bladder mucous membrane 
irritation leading to urgency and UUI (25, 26). 
High BMI is a strong independent risk factor for 
UI and the mechanism of the onset of the 
disorder is that excessive body weight leads to 
an increase in intra-abdominal pressure which 
causes increased intravesical pressure, 
expanded mobility of the bladder neck and 
urethra, and also causes instability of the 
bladder detrusor, all leading to involuntary urine 
leakage (27). Menopause and partner status are 
important predictors for female sexual 
dysfunction (28). 
Interrelation of urinary incontinence, 
emotional, mental and sexual health 
UI has a negative impact on the quality of life of 
women, emotional health, physical and mental 
condition, impairs relationships, affects careers, 
and is also an additional financial burden (29, 30, 
31). All incontinence types are associated with 
low self-esteem and a higher probability of 
psychiatric disease (32). The studies show higher 
levels of anxiety and psychological stress in 
women with UI (33). Nowadays women lead 
active lives and are trying to maintain a healthy 
body condition and normal sex life regardless of 
age. UI has been recognized as one of the 
predictors of female sexual dysfunction 
considering excessive acetylcholine release on 
the bladder during intercourse, increased intra-
abdominal pressure with alteration of the 
urethrovesical angle and elevation of the 
bladder neck during intercourse, because of the 
fact that squamous epithelium of the trigone and 
urethra becomes thin and blood flow decreases 
with reducing estrogen in older postmenopausal 
women and the function of the main pelvic floor 
muscles deteriorates with age (34, 35). Urine 
leakage during orgasm may be caused by 
involuntary detrusor contraction and relaxation 
of the urethra (36). Involuntary urine leakage 
during sex is mainly a female problem because 
when a man has an erection the internal 
sphincter at the base of his bladder closes so 
urine can’t pass into urethra (37, 38). Between 25 
and 50% of women with UI experience 
decreased libido and decreased frequency of 
sexual activity because of the shame and fear of 
incontinence (39, 40). The incidence of UI during 
sexual intercourse in incontinent women has 
been reported to range between 10% and 27% 
(41). Recent studies reported high prevalence of 
CUI with results between 60% and 67% (42). The 
Pelvic Organ Prolapse/Urinary Incontinence 
Sexual Questionnaire (PISQ) and its short form 
version PISQ-12 are validated condition-specific 
female sexual function questionnaires 
purposively developed to assess sexual function 
in women with UI and/or pelvic organ prolapse 
(43, 44). Patients with a MUI diagnosis had 
significantly lower mean PISQ-12 scores than the 
ones with SUI and UUI, and patients with SUI had 
significantly lower PISQ-12 scores than those 
with UUI (45). On the other hand, one study 
showed that among sexually active women with 
UI, sexual function as assessed by the PISQ-12 
does not differ according to type of incontinence 
(46). The result of one study was similar to most 
other research and actually established that the 
rate of overall female sexual dysfunction in 
women with UUI was higher than in those with 
SUI, that CUI was more frequent in women with 
UUI than in those with SUI, but that feelings of 
pain and impressions of more involuntary urine 
leakage during sexual intercourse were more 
common in women with SUI than in those with 
UUI (40). Some researchers have found that CUI 
was present to a greater degree in young 
women than in elderly women and more 
frequent in women younger than 60 years of age 
(40, 47). In one study, 80% of women had 
incontinence during penetration, 93% had 
incontinence at orgasm and 92% had 
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incontinence in both cases, indicating CUI as a 
common symptom during sexual activity in 
women with SUI and suggesting urethral 
dysfunction as the possible explanation of CUI 
(11). Maximal urethral closure pressure < 30 
cmH2O was associated with CUI pointing out 
that urethral function plays a vital role in 
maintaining continence during coitus (48). In 
another report, 46% of women had UUI which 
led to the termination of sexual activity without 
orgasm and the rate of female sexual 
dysfunction was detected to be higher in 
women with UUI compared to that in the general 
population (49). Gynecologists and urologists 
need to pay more attention to sexual 
dysfunction in women with UI in their clinical 
practice. Additionally, one important thing to 
take into account is detailed medical history and 
sexual history of the occurring disorders during 
intercourse. 
Treatment options 
Once inflammation or anatomical disorders of 
the urinary system, neurological disease or 
cancer are ruled out, the following conservative 
and surgical treatment methods are available, 
most of which are scientifically proven with a 
high level of evidence and explained in the 2017 
European Association of Urology guidelines: 
open communication with one’s sexual partner, 
counseling with a therapist who specializes in 
sexual and relationship problems, bladder 
training, urinating prior to sexual intercourse, 
deferring intercourse, interrupting intercourse 
prematurely, avoiding certain positions, hurrying 
through sex, avoiding orgasm, regular physical 
activity and weight loss, smoking cessation, 
exercises to strengthen pelvic muscles, drug 
therapy (anticholinergics and ß3-agonist), 
periurethral bulking agents, intravesical 
Onabotulinumtoxin A injections, midurethral 
synthetic sling insertion, colposuspension and 
pubovaginal slings (50, 51, 52, 53, 54). The 
success rate is around 51% to 91% depending on 
the method, definition of cure and follow-up of 
every patient (55). In most cases, women try to 
perform the exercises of the pelvic floor on their 
own, in the comfort of their home, but without 
much success because they're not doing the 
exercises correctly. The efficiency of exercises 
can be increased if women exercise together 
with a specialized pelvic floor therapist. Oral 
anticholinergics and ß3-agonists are the 
mainstay of pharmacological treatment, but 
they have side effects leading to a high 
discontinuation rate. It has been observed that in 
60% of cases anticholinergic therapy leads to 
improvement of disorders during intercourse in 
women with UI (56, 57). Intradetrusor injection of 
100 units of Onabotulinumtoxin A significantly 
decreased the daily frequency of UI with 
clinically relevant improvement of symptoms 
and health related quality of life in patients 
inadequately treated with anticholinergics (58, 
59). The midurethral synthetic sling insertion has 
become the “gold standard” of surgical 
treatment of SUI (60). In women who do not wish 
to have surgery or in whom surgical options are 
restricted (e.g. after irradiation), bulking agents 
should be considered as an alternative strategy 
because they are a minimally invasive approach 
to treat SUI (61). Their use should not be 
proposed as first-line treatment in women 
seeking a permanent cure for both primary and 
recurrent SUI (61). 
Conclusion 
UI is associated with a profound sense of 
humiliation and it is subject to social stigma and 
prejudices (4). UI and incontinence during sexual 
intercourse is still a taboo subject and many 
women feel uncomfortable talking openly about 
it. According to some estimates only 20% of 
women with UI seek help because of the 
problems that arise during sexual intercourse. 
There are many methods women can use to 
reduce the possibility of uncontrolled leakage 
during sex while working on a durable solution. 
It isn't an easy topic to discuss with one’s sexual 
partner but the talk is necessary if the outcome 
is returning to the previous pleasurable sexual 
life. The treatment of UI and incontinence during 
sexual intercourse requires multidisciplinary 
teamwork and cooperation among specialists, 
sexual partners and society. Conservative and 
surgical treatment of UI, irrespective of the type, 
can improve quality of life and enhance 
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sexuality, but for more distinct conclusion 
further studies are needed. 
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